675P HER2 expression in circulating tumour cells is associated with poor outcomes in patients with metastatic castration resistant prostate cancer

Autor:	Gilles Freyer, Julien Péron, D. Maillet, S. Crouzet, A. Plesa, M. Decaussin, S. Tartas, Alain Ruffion, N. Allioli, V. Vlaeminck-Guillem
Rok vydání:	2020
Předmět:	Oncology Prostate cancer medicine.medical_specialty Her2 expression business.industry Internal medicine medicine In patient Hematology Castration resistant medicine.disease business
Zdroj:	Annals of Oncology. 31:S540
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.08.934
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4e537920a2796c9fc5cc071e2bbaea99 https://doi.org/10.1016/j.annonc.2020.08.934 Zobrazit plný text záznamu